Fluvoxamine






408 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 1389950 Inhibitors of imipramine metabolism by human liver microsomes. Br J Clin Pharmacol 1992 Sep 1
2 1389951 The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes. Br J Clin Pharmacol 1992 Sep 1
3 1933139 Inhibition of reflex responses of neonate rat lumbar spinal cord by 5-hydroxytryptamine. Br J Pharmacol 1991 Jul 1
4 2464912 Treatment of alcoholic organic brain syndrome with the serotonin reuptake inhibitor fluvoxamine: a preliminary study. Adv Alcohol Subst Abuse 1988 2
5 6134546 Neuroendocrine studies with fluvoxamine: animal data. Br J Clin Pharmacol 1983 1
6 6777458 Clovoxamine and fluvoxamine-2 biogenic amine re-uptake inhibiting antidepressants: quantitative EEG, psychometric and pharmacokinetic studies in man. J Neural Transm 1980 1
7 7479582 Cytochrome P4502E1 inhibition by propylene glycol prevents acetaminophen (paracetamol) hepatotoxicity in mice without cytochrome P4501A2 inhibition. Pharmacol Toxicol 1995 Jun 1
8 7494384 5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice. Jpn J Pharmacol 1995 May 3
9 7494385 Neither the 5-HT1A- nor the 5-HT2-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on forced-swimming-induced immobility in mice. Jpn J Pharmacol 1995 May 4
10 7586931 Effect of cigarette smoking on fluvoxamine pharmacokinetics in humans. Clin Pharmacol Ther 1995 Oct 3
11 7617560 Kinetics and inhibition by fluvoxamine of phenacetin O-deethylation in V79 cells expressing human CYP1A2. Pharmacol Toxicol 1995 Apr 1
12 7622807 Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror. Int Clin Psychopharmacol 1995 Mar 4
13 7742153 Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine. Br J Clin Pharmacol 1995 Feb 5
14 7770611 Chronic treatment with fluvoxamine by osmotic minipumps fails to induce persistent functional changes in central 5-HT1A and 5-HT1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats. Psychopharmacology (Berl) 1995 Feb 1
15 7928004 Expression of a high-affinity serotonin transporter in human lymphocytes. Int J Immunopharmacol 1994 Jul 1
16 7938563 The efficacy of fluvoxamine in patients with severe depression. Prog Neuropsychopharmacol Biol Psychiatry 1994 Jul 1
17 7974626 Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: evidence from a therapeutic drug monitoring service. Ther Drug Monit 1994 Aug 1
18 8466541 Fluvoxamine is a potent inhibitor of cytochrome P4501A2. Biochem Pharmacol 1993 Mar 24 4
19 8567194 Cytochrome P450 monooxygenases and interactions of psychotropic drugs: a five-year update. Int J Psychiatry Med 1995 3
20 8587855 Antidepressant drug interactions and the cytochrome P450 system: a critical appraisal. Pharmacotherapy 1995 Nov-Dec 1
21 8610817 Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996 Mar 1
22 8685072 Fluvoxamine and fluoxetine: interaction studies with amitriptyline, clomipramine and neuroleptics in phenotyped patients. Pharmacol Res 1995 Jun 2
23 8732441 Are pharmacokinetic drug interactions with the SSRIs an issue? Int Clin Psychopharmacol 1996 Mar 2
24 8771220 T-lymphocyte concentrations of cholecystokinin-8 and beta-endorphin in eating disorders: II. Bulimia nervosa. Psychiatry Res 1995 Nov 29 1
25 8775761 Effects of fluvoxamine on the protein phosphorylation system associated with rat neuronal microtubules. Eur Neuropsychopharmacol 1995 2
26 8823236 Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity. Clin Pharmacol Ther 1996 Aug 7
27 8838442 Venlafaxine oxidation in vitro is catalysed by CYP2D6. Br J Clin Pharmacol 1996 Feb 1
28 8846617 Overview of the pharmacokinetics of fluvoxamine. Clin Pharmacokinet 1995 6
29 8846618 Antidepressant drug interactions and the cytochrome P450 system. The role of cytochrome P450 2D6. Clin Pharmacokinet 1995 5
30 8846619 Drug interactions and the cytochrome P450 system. The role of cytochrome P450 1A2. Clin Pharmacokinet 1995 3
31 8846620 Fluvoxamine. A review of global drug-drug interaction data. Clin Pharmacokinet 1995 1
32 8846622 Drug interactions and the cytochrome P450 system. The role of cytochrome P450 2C19. Clin Pharmacokinet 1995 1
33 8880055 Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine. Eur J Clin Pharmacol 1996 9
34 8885123 Bupropion plasma levels and CYP2D6 phenotype. Ther Drug Monit 1996 Oct 2
35 8904628 In vivo inhibition of CYP2C19 but not CYP2D6 by fluvoxamine. Br J Clin Pharmacol 1996 Oct 3
36 8944409 The effect of chronic fluvoxamine on hormonal and psychological responses to buspirone in normal volunteers. Psychopharmacology (Berl) 1996 Nov 2
37 8968657 Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors. Clin Pharmacokinet 1996 Dec 6
38 8986010 Phenacetin O-deethylation by human liver microsomes in vitro: inhibition by chemical probes, SSRI antidepressants, nefazodone and venlafaxine. Psychopharmacology (Berl) 1996 Dec 1
39 8986013 Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences of a fluvoxamine augmentation. Psychopharmacology (Berl) 1996 Dec 3
40 9029748 Griseofulvin and fluvoxamine interactions with the metabolism of theophylline. Ther Drug Monit 1997 Feb 1
41 9032002 Pharmacokinetic drug interaction potential of selective serotonin reuptake inhibitors. Int Clin Psychopharmacol 1996 Dec 3
42 9085405 Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks. Psychopharmacology (Berl) 1997 Feb 1
43 9090339 19F magnetic resonance spectroscopy investigation in vivo of acute and steady-state brain fluvoxamine levels in obsessive-compulsive disorder. Am J Psychiatry 1997 Apr 1
44 9105404 Distinction of CYP1A1 and CYP1A2 activity by selective inhibition using fluvoxamine and isosafrole. Biochem Pharmacol 1997 Feb 21 3
45 9147017 Effects of fluoxetine hydrochloride and fluvoxamine maleate on different preparations of isolated guinea pig and rat organ tissues. Gen Pharmacol 1997 Apr 1
46 9174682 Relationship between fluvoxamine pharmacokinetics and CYP2D6/CYP2C19 phenotype polymorphisms. Eur J Clin Pharmacol 1997 5
47 9184622 Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design. J Clin Psychiatry 1997 4
48 9209244 Influence of the CYP1A2 inhibitor fluvoxamine on tacrine pharmacokinetics in humans. Clin Pharmacol Ther 1997 Jun 1
49 9223030 ACTH 4-9 analogue facilitates the antiimmobility effect of antidepressants and dopamine agonists in swimming rats. J Physiol Pharmacol 1997 Jun 1
50 9232209 Plasma prolactin response to d-fenfluramine in obsessive-compulsive patients before and after fluvoxamine treatment. Biol Psychiatry 1997 Aug 1 2